MB
Michael Brian Bell
Chief Financial Officer

Michael Brian Bell insider trades: Guardant Health (GH) stock buys and sales

Chief Financial Officer, Guardant Health Last trade Jun 5, 2026 65 Form 4 filings
$8.8M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2017
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 5, 2026GH↓ Sell$257K
Mar 16, 2026GH↓ Sell$261K
Dec 5, 2025GH↓ Sell$8.3M
Nov 3, 2020CDNA↓ Sell$1.6M
May 6, 2020CDNA↓ Sell$1.7M
Jun 20, 2019CDNA↓ Sell$571K
May 20, 2019CDNA↓ Sell$71K
May 9, 2019CDNA↓ Sell$483K
Mar 1, 2019CDNA↓ Sell$408K
Feb 20, 2019CDNA↓ Sell$58K
Feb 15, 2019CDNA↓ Sell$714K
Sep 13, 2018CDNA↓ Sell$410K
Aug 14, 2018CDNA↓ Sell$210K
Aug 15, 2017CDNA↑ Buy$1K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other GH insiders

Open-market trades in the last 12 months

About Michael Brian Bell's insider trades

Michael Brian Bell is Chief Financial Officer at Guardant Health (GH). Since Aug 15, 2017, Michael has reported 1 open-market purchase worth $1K and 13 sales worth $15.0M on SEC Form 4. In the last 12 months: 3 sales ($8.8M).

Their filings also include shares withheld for taxes (38 filings), option exercises (37 filings), grants and awards (19 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.